Surgical Innovations Group PLC
LSE:SUN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Surgical Innovations Group PLC
Revenue
Surgical Innovations Group PLC
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Surgical Innovations Group PLC
LSE:SUN
|
Revenue
£11.6m
|
CAGR 3-Years
1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Revenue
$6.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Revenue
$1.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Revenue
£51.6m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
6%
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Revenue
£4m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
212%
|
CAGR 10-Years
N/A
|
|
|
Inspiration Healthcare Group PLC
LSE:IHC
|
Revenue
£45.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
21%
|
|
Surgical Innovations Group PLC
Glance View
Surgical Innovations Group Plc is a holding company, which engages in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and industrial markets. The Group sells branded products through its Elemental Healthcare Ltd. (Distribution) and independent healthcare distributors across the world and own label products through original equipment manufacturer (OEM) relationships. The firm operates through three segments: SI Brand, OEM and Distribution. The SI Brand segment is engaged in the research, development, manufacture and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. Its Distribution segment is engaged in the distribution of specialist medical products sold through its Elemental Healthcare Ltd.
See Also
What is Surgical Innovations Group PLC's Revenue?
Revenue
11.6m
GBP
Based on the financial report for Dec 31, 2025, Surgical Innovations Group PLC's Revenue amounts to 11.6m GBP.
What is Surgical Innovations Group PLC's Revenue growth rate?
Revenue CAGR 10Y
8%
Over the last year, the Revenue growth was -3%. The average annual Revenue growth rates for Surgical Innovations Group PLC have been 1% over the past three years , 13% over the past five years , and 8% over the past ten years .
